Literature DB >> 2033228

Ischemic colitis associated with dextroamphetamine use.

K L Beyer1, J T Bickel, J H Butt.   

Abstract

Ischemic colitis can be caused by a variety of medications including a number of sympathomimetic agents. We report the case of a 47-year-old narcoleptic man who had abdominal pain and rectal bleeding. The clinical, radiographic, and histologic findings supported the diagnosis of ischemic colitis associated with oral dextroamphetamine use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033228     DOI: 10.1097/00004836-199104000-00016

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

Review 1.  Amphetamine abuse and intracranial haemorrhage.

Authors:  N Buxton; N S McConachie
Journal:  J R Soc Med       Date:  2000-09       Impact factor: 5.344

2.  Methamphetamine-associated shock with intestinal infarction.

Authors:  Temple A Brannan; Suganthi Soundararajan; Bruce L Houghton
Journal:  MedGenMed       Date:  2004-12-29

3.  Spectrum of ischemic colitis in cocaine users.

Authors:  M Niazi; A Kondru; J Levy; A A Bloom
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 4.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

5.  Massive hematochezia: a complication of methamphetamine-induced vasculitis treated by transcatheter hemostasis.

Authors:  Daniel P Link; Yung-Wei Chi
Journal:  Case Rep Radiol       Date:  2011-06-30

6.  Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats.

Authors:  Amanda L Persons; Brinda D Bradaric; Hemraj B Dodiya; Michael Ohene-Nyako; Christopher B Forsyth; Ali Keshavarzian; Maliha Shaikh; T Celeste Napier
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

7.  Altered fecal microbiota composition in individuals who abuse methamphetamine.

Authors:  Yongde Yang; Xuan Yu; Xuebing Liu; Guangya Liu; Kuan Zeng; Gang Wang
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.